Å·ÃÀAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

The 2nd Symposium on Transporters in Drug Discovery

15 May 2017 12:00 - 16 May 2017 16:10, London, United Kingdom


Introduction
Synopsis
Cell surface transporters play a key role in human health and disease, both through their impact on drug disposition and as therapeutic targets in their own right.   This meeting continues on from the first, successfully held in 2014, and is anticipated to become part of a regular series. It should be of interest to medicinal chemists, DMPK scientists and other workers with interests on the impact of transporters on human health.

Features of the Meeting
The conference programme will cover:
•    Lectures on transporter structural biology, the impact of transporters on ADME and biodistribution, transporters as therapeutic targets and the toxicological impact of transporter interactions on drug development
•    Poster session
•    Related trade exhibition

Call for Papers
Abstracts for oral presentation are sought, but for Transporters and Therapeutic Targets only.   Abstracts for poster presentations are also invited, and a template is available on the event website.  Posters will be displayed throughout the meeting.

Accommodation
Suggestions of nearby hotels will be available on our website.

Sponsorship and Exhibition Opportunities
There will be a relevant trade exhibition, and further details will be available from the secretariat.    Sponsors are encouraged to support this second event.

Registration and Students
Discounted rates are offered to members of the Å·ÃÀAV, SCI and DMDG, and some students bursaries are available.
Speakers
  • David Hepworth Pfizer, United States
  • Amin Rostami University of Manchester, United Kingdom
  • Liz Carpenter SGC Oxford, United Kingdom
  • Rob Elsby Cyprotex, United Kingdom
  • Sarah Foley Evotec, United Kingdom
  • Elnaz Gozalpour AstraZeneca, United Kingdom
  • Philip Low Purdue University, United States
  • Johan Nicolaï UCB, Belgium
  • Venkatesh Pilla Reddy AstraZeneca, United Kingdom
  • Laurent Salphati Genentech, United States
  • Kunal Taskar GlaxoSmithKline, United Kingdom
  • Mohammed Ullah F Hoffmann-La Roche, Switzerland
  • Grace Liang Neurocrine, United States
  • Peter Henderson University of Leeds, United Kingdom
  • Oliver Langer Medical University of Vienna, Austria

Sponsorship & supporting organisations
Venue
The Å·ÃÀAV

The Library, The Å·ÃÀAV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Committee
Organised by
This event is organised by
  • Å·ÃÀAV BMCS (Å·ÃÀAV - Biological and Medicinal Chemistry Sector)
  • SCI FCG (Society of Chemical Industry - Fine Chemicals Group)
  • DMDG (Drug Metabolism Discussion Group)

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*